首页> 外文期刊>Journal of Drug Delivery and Therapeutics >DRUG UTILIZATION AND PRESCRIBING PATTERN OF GLAUCOMA IN A TERTIARY CARE HOSPITAL OF DEHRADUN
【24h】

DRUG UTILIZATION AND PRESCRIBING PATTERN OF GLAUCOMA IN A TERTIARY CARE HOSPITAL OF DEHRADUN

机译:德拉敦三级医院青光眼的药物利用与处方模式

获取原文
           

摘要

Glaucoma is a condition in which distinctive changes occur in the optic nerve and visual field. In glaucoma intraocular pressure (IOP) is raised that compresses and damages the optic nerve. As the optic nerve is damaged, it fails to carry the visual information to the brain which induce clinically progressive loss of peripheral visual field and ultimately loss of vision. AIMS AND OBJECTIVES: To Evaluate the drug utilization and prescribing pattern of drugs used for treatment of glaucoma, to analyze current prescribing trends in anti-glaucoma drugs, to perform a drug utilization study, to identify drugs per prescription, category wise identification of drugs prescribed, mono therapy vs combination therapy. MATERIALS AND METHODS : The present study was a prospective, observational study carried out in 105 patients at Shri Mahant Indiresh Hospital, Dehradun, Uttarakhand, India. RESULTS: Out of total 105 patients, 68 were males (64.76%) and 37 were females (35.24%). The most common age group was 46-60 years. Patients were mostly affected by primary open angle glaucoma (95.23%) then angle closer glaucoma (4.76%). Total 184 drugs were prescribed in the treatment of glaucoma. Average number of drugs per prescription was 1.75. Combination therapy was prescribed in 51.43% patients & most common used combination therapy was combination of Brimonidine+ timolol (81.48%) followed by Bimatoprost+ timolol (18.52%). Monotherapy was used in 48.57% patients in which drug dorzolamide (22.31%) was prescribed mostly which is belongs to the category of carbonic anhydrase inhibitors followed by timolol (19.23%) (β- blockers) which was second line choice of drug. Generic drugs were mostly prescribed in 77 patients (73.33%) followed by 28 patients (26.66%) were brand names. CONCLUSION: The prescription analysis of glaucoma patients concluded that monotherapy with dorzolamide was the first line choice for glaucoma therapy and timolol was found to be the second line choice. Timolol+ brimonidine was the mostly prescribed combination of drug. It also showed that all drugs were prescribed in their generic name instead of brand name.
机译:青光眼是一种在视神经和视野中发生明显变化的疾病。在青光眼中,眼内压(IOP)升高,压缩并损伤了视神经。由于视神经受损,它无法将视觉信息传递到大脑,从而导致临床上逐渐丧失周围视野,最终导致视力丧失。目的和目标:评估用于治疗青光眼的药物的利用率和处方方式,分析抗青光眼药物的当前处方趋势,进行药物利用研究,按处方确定药物,对处方药物进行类别识别,单一疗法与联合疗法。材料与方法:本研究是对印度北阿坎德邦德拉邦的Shri Mahant Indiresh医院的105例患者进行的前瞻性观察研究。结果:在总共105例患者中,男性68例(64.76%),女性37例(35.24%)。最常见的年龄组是46-60岁。患者主要受原发性开角型青光眼(95.23%),然后是闭角型青光眼(4.76%)的影响。总共有184种药物被处方用于治疗青光眼。每个处方药的平均数量为1.75。 51.43%的患者开了联合疗法,最常用的联合疗法是溴莫尼定+噻吗洛尔(81.48%),然后是比马前列素+噻吗洛尔(18.52%)。在48.57%的患者中使用了单一疗法,其中处方了多佐胺(22.31%)的药物主要属于碳酸酐酶抑制剂,其次是噻吗洛尔(19.23%)(β-受体阻滞剂),后者是药物的二线选择。仿制药主要在77名患者中开处方(73.33%),其次是28名患者(26.66%)。结论:青光眼患者的处方分析得出结论,多佐胺单药治疗是青光眼治疗的第一线选择,而噻吗洛尔是第二线治疗。替莫洛尔+溴莫尼定是大多数处方药。它还显示所有药物均以其通用名称而非品牌名称开出处方。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号